Tag: NASDAQ: ACRX

Business

ACRX, ATER, WISH, OCGN Investors Alert: Class Action Lawsuit

Four publicly traded companies are facing class-action lawsuits. This is the investors’ alert.  AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) deadline alert AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is facing a class-action lawsuit. Bronstein, Gewirtz & Grossman, LLC is looking into the investigation part of this lawsuit filed against the publicly traded company. […]

Business

Cloopen Group Holding Limited (NYSE: RAAS), Athira Pharma Inc. (NASDAQ: ATHA), and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) Face Securities Laws Violation Lawsuit

Cloopen Group Holding Limited (NYSE: RAAS), Athira Pharma Inc. (NASDAQ: ATHA), and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) are under investigation for potential federal securities laws violation.  AcelRx’s lead candidate DSUVIA  AcelRx develops acute pain treatment therapies, and its lead candidate DSUVIA, has FDA approval for acute pain management. On February […]